Novo Nordisk A/S
-
Travel
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
https://insurancehubex.online/wp-admin/options-general.php?page=ad-inserter.php#tab-6 An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11,…
Read More » -
USA Insurance
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
https://insurancehubex.online/wp-admin/options-general.php?page=ad-inserter.php#tab-6 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday,…
Read More » -
USA Insurance
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
https://insurancehubex.online/wp-admin/options-general.php?page=ad-inserter.php#tab-6 The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Read More » -
Life Style
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
https://insurancehubex.online/wp-admin/options-general.php?page=ad-inserter.php#tab-6 Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8,…
Read More » -
USA Insurance
Amgen stock falls as analysts mull over weight loss drug’s bone density data
https://insurancehubex.online/wp-admin/options-general.php?page=ad-inserter.php#tab-6 Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage…
Read More »